文献速递肺外科

中心与周围型小尺寸实性优势NSCLC的肿瘤学特征比较

Comparative oncological features of centrally and peripherally located small-sized radiologically solid-dominant non-small-cell lung cancer.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

该回顾性研究纳入1240例≤2 cm、影像学实性优势、cN0的非小细胞肺癌患者,比较中心型(299例)与周围型(941例)肿瘤的临床病理特征与预后。中心型肿瘤纯实性比例和病理淋巴结升级比例更高,中心位置是pN1升级的独立预测因素,但两组局部区域复发、远处复发及生存率无显著差异。

要点

  • 中心型≤2 cm实性优势cN0 NSCLC的pN1升级风险更高(OR 1.91)。
  • 中心型与周围型肿瘤的局部区域和远处复发率无显著差异。
  • 完全解剖性切除后两组总生存和无复发生存率相似。

核心结论

  • ≤2 cm影像学实性优势cN0 NSCLC完全解剖性切除后,中心型与周围型患者预后相当。
  • 中心型肿瘤与更高的pN1升级风险相关,提示需重视肺门淋巴结清扫。

研究设计与样本

  • 回顾性队列研究,纳入1240例接受肺叶或肺段切除的≤2 cm影像学实性优势cN0 NSCLC患者。
  • 肿瘤按位置分为中心型(肺实质内2/3,299例)和周围型(外1/3,941例)。

主要发现

  • 中心型肿瘤纯实性肿瘤比例显著高于周围型(P=0.018)。
  • 中心型肿瘤病理淋巴结升级比例显著高于周围型(P=0.038)。
  • 多变量logistic回归显示中心位置是pN1升级的独立预测因素(OR=1.91,95%CI 1.09-3.36,P=0.024),但对pN2升级不是。
  • 两组局部区域复发累积发生率(P=0.455)和远处复发累积发生率(P=0.383)无显著差异。
  • 两组总生存率(P=0.267)和无复发生存率(P=0.269)相似。

临床怎么用

  • 对于中心型≤2 cm实性优势cN0 NSCLC,应行彻底的肺门淋巴结清扫以准确分期。
  • 中心型与周围型肿瘤患者术后预后相似,解剖性切除是合理选择。

局限性

  • 回顾性研究设计。
  • 单中心数据可能影响外推性。
  • 未报告具体淋巴结清扫范围对分期的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to compare the oncological features of centrally and peripherally located small-sized (≤2 cm), radiologically solid-dominant, cN0 non-small-cell lung cancer (NSCLC). METHODS: We retrospectively reviewed 1240 patients who underwent lobectomy or segmentectomy for radiologically solid-dominant cN0 NSCLC tumours ≤2 cm in size. Tumours were categorized as centrally (inner two-thirds of the pulmonary parenchyma) or peripherally (outer one-third) located. Clinicopathological characteristics and prognoses were compared between the 2 groups. RESULTS: Among the 1240 patients, 299 had centrally located and 941 had peripherally located tumours. Centrally located tumours showed a significantly higher proportion of pure solid tumours and pathological lymph node upstaging than peripherally located tumours (P = 0.018 and P = 0.038, respectively). Multivariable logistic regression analysis identified central location as an independent predictor for pN1 (odds ratio, 1.91; 95% confidence interval, 1.09-3.36; P = 0.024), but not for pN2, upstaging. The cumulative incidence of loco-regional and distant recurrences did not significantly differ between the 2 groups (P = 0.455 and P = 0.383, respectively). Overall survival and recurrence-free survival rates were also similar among patients with central and peripheral tumours (P = 0.267 and P = 0.269, respectively). CONCLUSIONS: Patient prognosis following complete anatomical resection was comparable between centrally and peripherally located radiologically solid-dominant cN0 NSCLC tumours ≤2 cm in size. However, centrally located tumours were associated with a higher risk of pN1 upstaging, highlighting the importance of thorough hilar lymph node dissection in these patients.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Tsubokawa N, Mimae T, Miyata Y, et al. Comparative oncological features of centrally and peripherally located small-sized radiologically solid-dominant non-small-cell lung cancer. Eur J Cardiothorac Surg. 2025. PMID: 40220322. doi:10.1093/ejcts/ezaf072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。